Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myeloid Leukemia (Relapsed/Refractory)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00015925
What this trial is testing

MS-275 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT02996474
What this trial is testing

Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Relapsed Acute Myeloid Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 10
Early research (Phase 1)Looking for participantsNCT07347418
What this trial is testing

CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

Who this might be right for
Refractory Acute Myeloid Leukemia (AML)Relapsed Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome+1 more
University of Colorado, Denver 23
Testing effectiveness (Phase 2)Study completedNCT00044889
What this trial is testing

Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
Genzyme, a Sanofi Company 40
Not applicableUnknownNCT04692948
What this trial is testing

TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia

Who this might be right for
CARAcute Myeloid Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 5
Testing effectiveness (Phase 2)Ended earlyNCT02337478
What this trial is testing

Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Adult Acute Myeloid Leukemia
Wake Forest University Health Sciences 5
Testing effectiveness (Phase 2)Study completedNCT03008187
What this trial is testing

MEN1703 (SEL24) in Participants With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Menarini Group 73
Testing effectiveness (Phase 2)UnknownNCT01180426
What this trial is testing

Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Chroma Therapeutics 30
Not applicableUnknownNCT06233526
What this trial is testing

Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test

Who this might be right for
Acute Myeloid Leukemia in Children
The Children's Hospital of Zhejiang University School of Medicine 60
Testing effectiveness (Phase 2)Study completedNCT01702155
What this trial is testing

Phase I/II Study of DFP-10917 in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic Leukemia
Delta-Fly Pharma, Inc. 69
Testing effectiveness (Phase 2)Ended earlyNCT00374296
What this trial is testing

MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease

Who this might be right for
Myelogenous Leukemia, AcuteMyelodysplastic Syndromes
Mirati Therapeutics Inc. 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755202
What this trial is testing

Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory Leukemia

Who this might be right for
Acute Myeloid LeukemiaAML With FLT3 Mutation
Florian Kuchenbauer 20
Testing effectiveness (Phase 2)UnknownNCT04541277
What this trial is testing

Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia, in Relapsed or RefractoryAcute Myeloid Leukemia, Elderly, UnfitAcute Myeloid Leukemia With Positive Minimal Residual Disease
Chinese PLA General Hospital 55
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Testing effectiveness (Phase 2)Study completedNCT00354146
What this trial is testing

Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.

Who this might be right for
Leukemia, Nonlymphocytic, Acute
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 252
Early research (Phase 1)Study completedNCT03081780
What this trial is testing

Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML

Who this might be right for
Refractory Acute Myelogenous LeukemiaRelapsed Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 6
Testing effectiveness (Phase 2)Study completedNCT00620321
What this trial is testing

LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Eli Lilly and Company 24
Early research (Phase 1)Study completedNCT04926285
What this trial is testing

Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Relapsed or Refractory Hematologic Malignancies
University of Illinois at Chicago 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07486726
What this trial is testing

Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)Relapse Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia (AML)
Shanghai Jiao Tong University School of Medicine 112
Early research (Phase 1)UnknownNCT02859948
What this trial is testing

SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 18
Next Page